Highest Upside

Coromandel International (CRIN) continued to deliver healthy operating performance in 2QFY26 (EBIT up 15% YoY), supported by continued traction in crop protection (EBIT up 34% YoY) and nutrients and allied (EBIT up 16% YoY).

The company aims to enhance capacity utilization through backward integration, with the launch of new products is expected to strengthen its near-term revenue outlook. New segments such as drones and retail, along with stabilized raw material prices and operational improvements, are likely to support profitability going forward. Accordingly, we revise our rating on the stock to ACCUMULATE, with a revised...

Q1FY2026 Consolidated revenue of Rs. 7,042 crore was up 49% y-o-y. Revenues increased due to strong volume growth in the fertilizer and the crop protection business and increase in subsidy.